XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitair Ziekenhuis Gent
Ghent, Belgium
- British Columbia Cancer Agency - Vancouver Centre
Vancouver, British Columbia, Canada
- London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Centre Hospitalier Universite de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Chu - Hospital Jean Minjoz
Besançon, France
- Hospital Ambroise Pare
Boulogne-Billancourt, France
- Centre Oscar Lambret
Lille, France
- Institut Gustave Roussy
Villejuif, France
- Charite Berlin Der Humbold Universitat
Berlin, Germany
- Heinrich-Heine-Universitat-Dusseldorf
Düsseldorf, Germany
- Allgem. Krankenhaus St. Georg
Hamburg, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Universitätsklinikum Johannes Gutenberg
Mainz, Germany
- Klinikum Grosshadern Der Ludwig Maximilians Universitaet
Munich, Germany
- Technischen Universitat Munchen
Munich, Germany
- Universitätsklinikum Tübingen
Tübingen, Germany
- Universitatsklinikum Ulm
Ulm, Germany
- Orszagos Onkologiai Intezet
Budapest, Hungary
- Centro Di Riferimento Oncologico Di Aviano
Aviano, Italy
- Ospidale Civile Di Livorno
Livorno, Italy
- Policlinico Universitario Di Udine
Udine, Italy
- Centrum Onkologii - Instytut Im. Marii
Warsaw, Poland
- Cancer Research Center Named After N.N. Blokhin, Rams
Moscow, Russia
- Hospital Clinic I Provincial (oncology Department)
Barcelona, Spain
- Hospital 12 de Octubre
Madrid, Spain
- Hospital Clínico San Carlos
Madrid, Spain
- Hospital Regional Universitario Carlos Haya
Málaga, Spain
- Hospital Provincial de Pontevedra
Pontevedra, Spain
- Hospital Lozano Blesa
Zaragoza, Spain
- Leicester Royal Infirmary
Leicester, England, United Kingdom
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Long Beach Va Medical Center
Long Beach, California, United States
- University of California, Irvine Medical Center
Orange, California, United States
- Sharp Clinical Oncology Research
San Diego, California, United States
- Pacific Hematology Oncology Associates
San Francisco, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Tampa General Hospital
Tampa, Florida, United States
- Winship Cancer Institute, Emory University Hospital
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2004
- Primary completion
- 30 Nov 2006
- Completion
- 30 Nov 2006
- Last update posted
- 14 Jan 2009
- Registered enrollment
- 248
- Registry id
- NCT00090025
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.